ABT logo

Abbott Laboratories (ABT) Cash from investing

annual CFI:

-$2.34B+$795.00M(+25.38%)
December 31, 2024

Summary

  • As of today (May 31, 2025), ABT annual cash flow from investing activities is -$2.34 billion, with the most recent change of +$795.00 million (+25.38%) on December 31, 2024.
  • During the last 3 years, ABT annual CFI has fallen by -$330.00 million (-16.43%).
  • ABT annual CFI is now -453.71% below its all-time high of $661.00 million, reached on December 31, 2011.

Performance

ABT Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

quarterly CFI:

-$470.00M+$396.00M(+45.73%)
March 1, 2025

Summary

  • As of today (May 31, 2025), ABT quarterly cash flow from investing activities is -$470.00 million, with the most recent change of +$396.00 million (+45.73%) on March 1, 2025.
  • Over the past year, ABT quarterly CFI has dropped by -$45.00 million (-10.59%).
  • ABT quarterly CFI is now -126.63% below its all-time high of $1.76 billion, reached on December 31, 2011.

Performance

ABT quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

TTM CFI:

-$2.38B-$45.00M(-1.92%)
March 1, 2025

Summary

  • As of today (May 31, 2025), ABT TTM cash flow from investing activities is -$2.38 billion, with the most recent change of -$45.00 million (-1.92%) on March 1, 2025.
  • Over the past year, ABT TTM CFI has increased by +$713.00 million (+23.03%).
  • ABT TTM CFI is now -384.71% below its all-time high of $837.00 million, reached on March 31, 2016.

Performance

ABT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ABT Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.4%-10.6%+23.0%
3 y3 years-16.4%-30.6%-22.5%
5 y5 years-28.8%-19.6%-31.5%

ABT Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-34.4%+25.4%-78.0%+61.3%-37.0%+23.9%
5 y5-year-34.4%+25.4%-78.0%+61.3%-37.0%+23.9%
alltimeall time-453.7%+80.8%-126.6%+93.9%-384.7%+80.5%

ABT Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$470.00M(-45.7%)
-$2.38B(+1.9%)
Dec 2024
-$2.34B(-25.4%)
-$866.00M(+45.8%)
-$2.34B(+1.8%)
Sep 2024
-
-$594.00M(+31.1%)
-$2.30B(-1.7%)
Jun 2024
-
-$453.00M(+6.6%)
-$2.34B(-24.5%)
Mar 2024
-
-$425.00M(-48.4%)
-$3.10B(-1.2%)
Dec 2023
-$3.13B(+80.1%)
-$824.00M(+30.0%)
-$3.13B(+6.5%)
Sep 2023
-
-$634.00M(-47.7%)
-$2.94B(+5.4%)
Jun 2023
-
-$1.21B(+162.6%)
-$2.79B(+51.5%)
Mar 2023
-
-$462.00M(-26.9%)
-$1.84B(+5.9%)
Dec 2022
-$1.74B(-13.3%)
-$632.00M(+30.6%)
-$1.74B(-2.2%)
Sep 2022
-
-$484.00M(+83.3%)
-$1.78B(-8.6%)
Jun 2022
-
-$264.00M(-26.7%)
-$1.95B(0.0%)
Mar 2022
-
-$360.00M(-46.3%)
-$1.95B(-3.1%)
Dec 2021
-$2.01B(-9.3%)
-$671.00M(+3.1%)
-$2.01B(-2.9%)
Sep 2021
-
-$651.00M(+146.6%)
-$2.07B(+9.5%)
Jun 2021
-
-$264.00M(-37.4%)
-$1.89B(-15.8%)
Mar 2021
-
-$422.00M(-42.3%)
-$2.24B(+1.3%)
Dec 2020
-$2.21B(+22.0%)
-$731.00M(+54.9%)
-$2.21B(+12.3%)
Sep 2020
-
-$472.00M(-23.7%)
-$1.97B(+2.1%)
Jun 2020
-
-$619.00M(+57.5%)
-$1.93B(+6.7%)
Mar 2020
-
-$393.00M(-19.6%)
-$1.81B(-0.2%)
Dec 2019
-$1.81B(+33.8%)
-$489.00M(+13.2%)
-$1.81B(-0.4%)
Sep 2019
-
-$432.00M(-13.3%)
-$1.82B(+6.4%)
Jun 2019
-
-$498.00M(+25.8%)
-$1.71B(+13.1%)
Mar 2019
-
-$396.00M(-20.2%)
-$1.51B(+11.7%)
Dec 2018
-$1.36B(-85.9%)
-$496.00M(+53.6%)
-$1.36B(-66.2%)
Sep 2018
-
-$323.00M(+8.0%)
-$4.01B(+0.4%)
Jun 2018
-
-$299.00M(+25.6%)
-$4.00B(+7.9%)
Mar 2018
-
-$238.00M(-92.4%)
-$3.70B(-61.5%)
Dec 2017
-$9.62B(+3778.2%)
-$3.15B(+930.1%)
-$9.62B(+95.6%)
Sep 2017
-
-$306.00M(+5000.0%)
-$4.92B(-4.8%)
Jun 2017
-
-$6.00M(-99.9%)
-$5.16B(-22.1%)
Mar 2017
-
-$6.15B(-497.0%)
-$6.63B(+2572.6%)
Dec 2016
-$248.00M(-161.1%)
$1.55B(-379.8%)
-$248.00M(+6.9%)
Sep 2016
-
-$554.00M(-62.3%)
-$232.00M(-73.5%)
Jun 2016
-
-$1.47B(-750.4%)
-$875.00M(-204.5%)
Mar 2016
-
$226.00M(-85.6%)
$837.00M(+106.2%)
Dec 2015
$406.00M(-301.0%)
$1.57B(-230.8%)
$406.00M(-134.7%)
Sep 2015
-
-$1.20B(-594.6%)
-$1.17B(+46.6%)
Jun 2015
-
$242.00M(-218.0%)
-$798.00M(-524.5%)
Mar 2015
-
-$205.00M(+1950.0%)
$188.00M(-193.1%)
Dec 2014
-$202.00M(-94.9%)
-$10.00M(-98.8%)
-$202.00M(-131.2%)
Sep 2014
-
-$825.00M(-167.2%)
$648.00M(-152.9%)
Jun 2014
-
$1.23B(-306.4%)
-$1.22B(-49.3%)
Mar 2014
-
-$595.00M(-170.8%)
-$2.42B(-38.5%)
Dec 2013
-$3.93B(-29.3%)
$840.00M(-131.1%)
-$3.93B(-34.5%)
Sep 2013
-
-$2.70B(-7591.7%)
-$5.99B(+74.8%)
Jun 2013
-
$36.00M(-101.7%)
-$3.43B(+23.5%)
Mar 2013
-
-$2.11B(+72.1%)
-$2.78B(-50.1%)
Dec 2012
-$5.56B(-941.1%)
-$1.22B(+830.8%)
-$5.56B(+116.3%)
Sep 2012
-
-$131.61M(-119.1%)
-$2.57B(+77.7%)
Jun 2012
-
$688.37M(-114.1%)
-$1.45B(-25.0%)
Mar 2012
-
-$4.89B(-377.2%)
-$1.93B(-391.9%)
Dec 2011
$661.00M(-105.4%)
$1.76B(+77.9%)
$661.00M(-118.7%)
Sep 2011
-
$992.00M(+382.5%)
-$3.54B(-48.9%)
Jun 2011
-
$205.59M(-108.9%)
-$6.93B(+1.4%)
Mar 2011
-
-$2.30B(-5.7%)
-$6.83B(-44.0%)
Dec 2010
-$12.19B(+229.5%)
-$2.44B(+2.0%)
-$12.19B(+48.9%)
Sep 2010
-
-$2.39B(-887.6%)
-$8.19B(+12.0%)
Jun 2010
-
$303.83M(-104.0%)
-$7.31B(-25.0%)
Mar 2010
-
-$7.66B(-590.0%)
-$9.75B(+163.7%)
Dec 2009
-$3.70B(+77.2%)
$1.56B(-202.9%)
-$3.70B(-34.1%)
Sep 2009
-
-$1.52B(-29.0%)
-$5.61B(+35.3%)
Jun 2009
-
-$2.14B(+33.1%)
-$4.15B(+48.2%)
Mar 2009
-
-$1.61B(+355.9%)
-$2.80B(+34.1%)
Dec 2008
-$2.09B(+83.7%)
-$352.19M(+551.0%)
-$2.09B(+6.3%)
Sep 2008
-
-$54.10M(-93.1%)
-$1.96B(-13.4%)
Jun 2008
-
-$788.04M(-11.8%)
-$2.27B(+38.2%)
Mar 2008
-
-$893.16M(+291.1%)
-$1.64B(+44.4%)
Dec 2007
-$1.14B
-$228.36M(-36.3%)
-$1.14B(-76.5%)
Sep 2007
-
-$358.28M(+123.0%)
-$4.83B(-0.1%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$160.66M(-58.7%)
-$4.83B(-57.9%)
Mar 2007
-
-$388.98M(-90.1%)
-$11.49B(+0.8%)
Dec 2006
-$11.40B(+1482.8%)
-$3.92B(+975.4%)
-$11.40B(+41.8%)
Sep 2006
-
-$364.58M(-94.7%)
-$8.04B(+1.0%)
Jun 2006
-
-$6.82B(+2233.0%)
-$7.96B(+467.0%)
Mar 2006
-
-$292.33M(-48.0%)
-$1.40B(+94.9%)
Dec 2005
-$720.09M(-81.9%)
-$561.64M(+98.6%)
-$720.09M(+20.6%)
Sep 2005
-
-$282.76M(+6.1%)
-$597.21M(+2.1%)
Jun 2005
-
-$266.49M(-168.2%)
-$584.64M(-75.0%)
Mar 2005
-
$390.80M(-189.1%)
-$2.34B(-41.2%)
Dec 2004
-$3.98B(+177.1%)
-$438.76M(+62.4%)
-$3.98B(-1.0%)
Sep 2004
-
-$270.20M(-86.6%)
-$4.02B(-3.5%)
Jun 2004
-
-$2.02B(+61.7%)
-$4.17B(+72.3%)
Mar 2004
-
-$1.25B(+161.1%)
-$2.42B(+68.4%)
Dec 2003
-$1.44B(-15.0%)
-$478.96M(+15.0%)
-$1.44B(+27.6%)
Sep 2003
-
-$416.57M(+52.4%)
-$1.13B(+7.1%)
Jun 2003
-
-$273.26M(+1.8%)
-$1.05B(-36.7%)
Mar 2003
-
-$268.39M(+59.4%)
-$1.66B(-1.6%)
Dec 2002
-$1.69B(-79.8%)
-$168.33M(-50.8%)
-$1.69B(-20.2%)
Sep 2002
-
-$342.14M(-61.3%)
-$2.12B(-10.5%)
Jun 2002
-
-$884.39M(+199.0%)
-$2.37B(+15.5%)
Mar 2002
-
-$295.81M(-50.3%)
-$2.05B(-75.6%)
Dec 2001
-$8.38B(+1257.5%)
-$595.38M(+0.7%)
-$8.38B(+4.4%)
Sep 2001
-
-$591.13M(+4.2%)
-$8.03B(+7.5%)
Jun 2001
-
-$567.08M(-91.4%)
-$7.47B(+4.5%)
Mar 2001
-
-$6.63B(+2661.2%)
-$7.15B(+1057.2%)
Dec 2000
-$617.66M(-48.5%)
-$240.16M(+671.2%)
-$617.66M(-22.8%)
Sep 2000
-
-$31.14M(-87.3%)
-$799.91M(-31.3%)
Jun 2000
-
-$244.91M(+141.4%)
-$1.17B(-1.7%)
Mar 2000
-
-$101.45M(-76.0%)
-$1.19B(-1.0%)
Dec 1999
-$1.20B(-18.6%)
-$422.41M(+6.6%)
-$1.20B(+1.9%)
Sep 1999
-
-$396.29M(+49.3%)
-$1.18B(+20.1%)
Jun 1999
-
-$265.48M(+132.8%)
-$978.78M(-28.5%)
Mar 1999
-
-$114.02M(-71.5%)
-$1.37B(-7.0%)
Dec 1998
-$1.47B(+18.5%)
-$400.20M(+101.0%)
-$1.47B(+5.8%)
Sep 1998
-
-$199.09M(-69.6%)
-$1.39B(-7.8%)
Jun 1998
-
-$654.82M(+201.3%)
-$1.51B(+19.7%)
Mar 1998
-
-$217.30M(-31.9%)
-$1.26B(+1.5%)
Dec 1997
-$1.24B(-36.5%)
-$319.30M(+1.0%)
-$1.24B(-5.6%)
Sep 1997
-
-$316.02M(-22.4%)
-$1.31B(+4.6%)
Jun 1997
-
-$407.16M(+104.8%)
-$1.26B(-35.4%)
Mar 1997
-
-$198.82M(-49.3%)
-$1.94B(-0.5%)
Dec 1996
-$1.96B(+88.4%)
-$392.27M(+51.8%)
-$1.96B(+11.2%)
Sep 1996
-
-$258.33M(-76.4%)
-$1.76B(-0.3%)
Jun 1996
-
-$1.10B(+423.0%)
-$1.76B(+107.2%)
Mar 1996
-
-$209.40M(+7.2%)
-$851.00M(-18.0%)
Dec 1995
-$1.04B(+9.9%)
-$195.30M(-26.0%)
-$1.04B(+0.3%)
Sep 1995
-
-$263.78M(+44.5%)
-$1.03B(-2.5%)
Jun 1995
-
-$182.51M(-53.9%)
-$1.06B(-4.8%)
Mar 1995
-
-$396.13M(+105.8%)
-$1.11B(+18.1%)
Dec 1994
-$944.09M(+18.9%)
-$192.49M(-33.6%)
-$944.09M(+10.6%)
Sep 1994
-
-$290.07M(+22.8%)
-$853.34M(+11.8%)
Jun 1994
-
-$236.24M(+4.9%)
-$763.17M(-2.2%)
Mar 1994
-
-$225.29M(+121.4%)
-$780.13M(-1.7%)
Dec 1993
-$793.84M(+18.9%)
-$101.74M(-49.1%)
-$793.84M(-17.0%)
Sep 1993
-
-$199.90M(-21.1%)
-$956.20M(-4.4%)
Jun 1993
-
-$253.20M(+5.9%)
-$999.80M(+50.4%)
Mar 1993
-
-$239.00M(-9.5%)
-$664.70M(-0.4%)
Dec 1992
-$667.60M(+4.0%)
-$264.10M(+8.5%)
-$667.60M(+2.2%)
Sep 1992
-
-$243.50M(-397.3%)
-$653.40M(+11.5%)
Jun 1992
-
$81.90M(-133.9%)
-$586.10M(-33.8%)
Mar 1992
-
-$241.90M(-3.2%)
-$885.90M(+38.0%)
Dec 1991
-$642.10M(+3.8%)
-$249.90M(+41.8%)
-$642.10M(+56.5%)
Sep 1991
-
-$176.20M(-19.1%)
-$410.30M(+2.9%)
Jun 1991
-
-$217.90M(<-9900.0%)
-$398.70M(-7.4%)
Mar 1991
-
$1.90M(-110.5%)
-$430.60M(-30.4%)
Dec 1990
-$618.30M(+57.6%)
-$18.10M(-89.0%)
-$618.30M(+3.0%)
Sep 1990
-
-$164.60M(-34.1%)
-$600.20M(+37.8%)
Jun 1990
-
-$249.80M(+34.4%)
-$435.60M(+134.4%)
Mar 1990
-
-$185.80M
-$185.80M
Dec 1989
-$392.20M
-
-

FAQ

  • What is Abbott Laboratories annual cash flow from investing activities?
  • What is the all time high annual CFI for Abbott Laboratories?
  • What is Abbott Laboratories annual CFI year-on-year change?
  • What is Abbott Laboratories quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Abbott Laboratories?
  • What is Abbott Laboratories quarterly CFI year-on-year change?
  • What is Abbott Laboratories TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Abbott Laboratories?
  • What is Abbott Laboratories TTM CFI year-on-year change?

What is Abbott Laboratories annual cash flow from investing activities?

The current annual CFI of ABT is -$2.34B

What is the all time high annual CFI for Abbott Laboratories?

Abbott Laboratories all-time high annual cash flow from investing activities is $661.00M

What is Abbott Laboratories annual CFI year-on-year change?

Over the past year, ABT annual cash flow from investing activities has changed by +$795.00M (+25.38%)

What is Abbott Laboratories quarterly cash flow from investing activities?

The current quarterly CFI of ABT is -$470.00M

What is the all time high quarterly CFI for Abbott Laboratories?

Abbott Laboratories all-time high quarterly cash flow from investing activities is $1.76B

What is Abbott Laboratories quarterly CFI year-on-year change?

Over the past year, ABT quarterly cash flow from investing activities has changed by -$45.00M (-10.59%)

What is Abbott Laboratories TTM cash flow from investing activities?

The current TTM CFI of ABT is -$2.38B

What is the all time high TTM CFI for Abbott Laboratories?

Abbott Laboratories all-time high TTM cash flow from investing activities is $837.00M

What is Abbott Laboratories TTM CFI year-on-year change?

Over the past year, ABT TTM cash flow from investing activities has changed by +$713.00M (+23.03%)
On this page